By Hugo Francisco de Souza Reviewed by Benedette Cuffari, M.Sc. Oct 31 2024 In a recent study published in Nature Medicine , researchers investigate the clinical efficacy of semaglutide in controlling excessively high urine albumin-to-creatinine ratio (UACR) among overweight patients with chronic kidney disease (CKD). Study:  Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial . Image Credit: